PRIAVOID - Trademark Details
Status: 700 - Registered
Serial Number
79226526
Registration Number
5582971
Word Mark
PRIAVOID
Status
700 - Registered
Status Date
2018-10-16
Filing Date
2017-06-20
Registration Number
5582971
Registration Date
2018-10-16
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2018-07-31
Attorney Name
Law Office Assigned Location Code
N60
Employee Name
RIEPEL, CHRISTINA MAXI
Statements
Goods and Services
Chemical substances for the production of pharmaceuticals; esters of fatty acids for use in pharmaceuticals; preservatives for pharmaceutical compounds; antimicrobial preservatives for pharmaceutical compounds; chemicals for the preparation being manufacturing and production of pharmaceuticals; antioxidants for the production of pharmaceutical products; chemical compounds for the preparation being manufacturing of pharmaceutical products; esters being viscose chemicals for the production of pharmaceutical products; preservatives for use in the pharmaceutical industry; softening agents being chemical agents for manufacturing for use during the preparation of pharmaceuticals; chemical products for use in the pharmaceutical industry, namely, for use in pharmaceutical manufacturing; active chemical ingredients for the use during the preparation being manufacturing of pharmaceuticals; biochemical compounds for scientific purposes; biochemical products, namely polypeptides for in vitro research applications; biochemical products, namely, chemical reagents for in vitro genetic technology; reagents for use in scientific apparatus for chemical and biological analysis; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
Goods and Services
Pharmaceuticals for the prevention and treatment of allergies and for the abatement of burns; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceuticals, namely, anti-infectives, immunostimulants; implantable pharmaceuticals namely, biological tissues grafts; serotherapeutic pharmaceuticals for treatment of meningitis and respiratory disorders; pharmaceutical drugs for treatment of Alzheimer's and dementia; medicated throat sprays; medicine for dental purpose; medicine for veterinary purpose, namely, bacteriostats; medicine for intestinal diseases; pharmaceutical preparations for human purposes, namely, for treatment of Alzheimer's and dementia; pharmaceuticals for the treatment of the autonomic nervous system; pharmaceuticals for the treatment of gastrointestinal diseases; pharmaceutical compounds and products for treatment of Alzheimer's and dementia; chemical and pharmaceutical products and preparations for medical purposes, namely, medical diagnostic reagents; antiepileptic pharmaceutical preparations; pharmaceutical compounds and substances for treatment of Alzheimer's and dementia; chemical compounds for pharmaceutical purpose, namely, for the diagnosis of pregnancy; pharmaceutical agents for metabolism; pharmaceutical agents for treatment of the intestines; pharmaceutical compounds for human use, namely, menstrual symptom treatment preparations; synthetic peptides for pharmaceutical purpose for the prevention and treatment of flu; pharmaceutical agents and compounds for the peripheral nervous system; pharmaceutical products for the treatment of infections; pharmaceutical products for the treatment of hyperlipidemias; crystals for therapeutical purpose being pharmaceutical products, namely, mineral preparations; pharmaceutical compounds for the prevention and treatment of metabolic disorder; pharmaceutical compounds for the treatment of kidney diseases; pharmaceutical compounds for the prevention and treatment of metabolic diseases; chemicals for pharmaceutical use, namely, chemical preparations for the diagnosis of pregnancy; pharmaceutical compounds for the treatment of a chemical imbalance; pharmaceutical preparations for the central nervous system; pharmaceutical compounds for the treatment of diabetes; pharmaceutical compounds for the treatment of Parkinson disease; pharmaceutical compounds for the treatment of multiple sclerosis; pharmaceutical compounds and substances for the prevention of cancer; pharmaceutical compounds and substances with analgesic properties; pharmaceutical compounds for the treatment of epilepsy, disorders of the intestines and of the sensory organs; pharmaceutical compounds for the prevention of disorders and diseases of the nervous system; pharmaceutical compounds and substances for the treatment of cancer and cardiovascular diseases; pharmaceutical compounds and substances for use in oncology; pharmaceutical products and substances for the treatment of gastrointestinal diseases; pharmaceutical compounds for the treatment of diseases of the central nervous system (CNS); biological preparations for treatment of neurological disorders; biological compounds for the treatment of cancer; biochemical compounds for the treatment of cancer and for pain treatment; biotechnological compounds for medical purpose, namely, bioactive pharmaceuticals for treatment of Alzheimer's and dementia; diagnostic biomarker reagents for medical purpose; bio-pharmaceuticals for the treatment of cancer
Goods and Services
Development of pharmaceutical compounds and drugs; research and development of vaccine and drugs; pharmaceutical product development in relation to drugs; pharmaceutical research, research regarding pharmaceuticals; conducting of quality control tests on pharmaceutical products; medical and pharmaceutical research services; pharmaceutical research and development services; pharmaceutical research and development; development of pharmaceutical products; evaluation of results from quality control tests conducted on goods and services in relation to pharmaceutical products; consulting with regard to pharmacology; laboratory research services with regard to pharmaceuticals; research in the field of pharmaceuticals; consulting with regard to pharmaceutical research and development; scientific research in the field of pharmacy; pharmaceutical product evaluation, namely services for the evaluation of the therapeutic effects of pharmaceuticals; research and development services for the pharmaceutical industry; research and development in the field of pharmacy and biotechnology; information technology (IT) consultancy services for pharmaceutical industry and health sector; quality assessment in the nature of quality testing, analysis and evaluation with regard to research in the field of pharmacogenetics; biochemical research; biological research; biological analysis; biological research services; biological development services; biological laboratory services; biochemical analysis; biomedical research; biotechnological research; research regarding biotechnologies; biotechnological research services; scientific research regarding biology; biological research and analysis; research in the field of biotechnology; consulting in the field of biology; consulting in the field of biochemistry; research and development in the field of biochemistry; research and development services in the field of biotechnology
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2018-02-12
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-02-12
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-02-12
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
98 - Unknown
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
98 - Unknown
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
98 - Unknown
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
11 - 1st New Owner Before Publication
Legal Entity Type
98 - Unknown
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
01 - Individual
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Fitzner & Frese PartGmbB
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1388277
International Registration Date
2017-06-20
International Publication Date
2018-02-08
International Renewal Date
2027-06-20
Auto Protection Date
2019-08-08
International Status
001 - Request for extension of protection established
International Status Date
2018-02-08
Priority Claimed In
True
Priority Claimed Date
2017-01-16
First Refusal In
True
Trademark Events
Event Date | Event Description |
2018-02-08 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2018-02-12 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-02-12 | ASSIGNED TO EXAMINER |
2018-02-16 | APPLICATION FILING RECEIPT MAILED |
2018-02-21 | NON-FINAL ACTION WRITTEN |
2018-02-22 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2018-03-02 | REFUSAL PROCESSED BY MPU |
2018-03-03 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2018-03-05 | NON-FINAL ACTION WRITTEN |
2018-03-06 | NON-FINAL ACTION MAILED |
2018-03-24 | REFUSAL PROCESSED BY IB |
2018-06-20 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2018-06-20 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-06-21 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-06-21 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2018-07-05 | CHANGE OF OWNER RECEIVED FROM IB |
2018-07-11 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2018-07-11 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2018-07-11 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2018-07-27 | NOTIFICATION PROCESSED BY IB |
2018-07-31 | PUBLISHED FOR OPPOSITION |
2018-07-31 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2018-10-16 | REGISTERED-PRINCIPAL REGISTER |
2019-01-16 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2019-01-31 | FINAL DISPOSITION PROCESSED |
2019-01-31 | FINAL DISPOSITION NOTICE SENT TO IB |
2019-02-22 | FINAL DECISION TRANSACTION PROCESSED BY IB |